Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9586 |
High Similarity |
NPD7808 |
Phase 3 |
0.9527 |
High Similarity |
NPD7251 |
Discontinued |
0.9467 |
High Similarity |
NPD6797 |
Phase 2 |
0.9408 |
High Similarity |
NPD7472 |
Approved |
0.9349 |
High Similarity |
NPD7054 |
Approved |
0.9294 |
High Similarity |
NPD7074 |
Phase 3 |
0.9244 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9059 |
High Similarity |
NPD6166 |
Phase 2 |
0.9059 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9059 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9012 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD3818 |
Discontinued |
0.88 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8706 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8698 |
High Similarity |
NPD3817 |
Phase 2 |
0.8538 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8488 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD1934 |
Approved |
0.843 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8324 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8314 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8256 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8242 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8232 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8176 |
Intermediate Similarity |
NPD5403 |
Approved |
0.814 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8107 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8066 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8059 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8033 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8023 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8021 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7989 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.797 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7957 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7944 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7912 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7849 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7833 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.779 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7772 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD919 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7709 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7677 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7674 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7662 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7626 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7626 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7626 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7624 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7562 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD37 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7473 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7462 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7448 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7446 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7426 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7399 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7363 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7358 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7326 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD6534 |
Approved |
0.731 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7294 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7294 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7283 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD447 |
Suspended |
0.725 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.722 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7193 |
Intermediate Similarity |
NPD943 |
Approved |
0.7184 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7088 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7074 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD920 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7056 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7056 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5353 |
Approved |
0.6974 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6966 |
Remote Similarity |
NPD1243 |
Approved |
0.6966 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6961 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6944 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6927 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7038 |
Approved |
0.6923 |
Remote Similarity |
NPD7039 |
Approved |
0.6915 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6906 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6882 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6882 |
Remote Similarity |
NPD1203 |
Approved |
0.6879 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6872 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.686 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6857 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD7930 |
Approved |
0.6854 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6836 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6833 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6828 |
Remote Similarity |
NPD6386 |
Approved |
0.6828 |
Remote Similarity |
NPD6385 |
Approved |
0.6823 |
Remote Similarity |
NPD5242 |
Approved |
0.6818 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6804 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6802 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD9494 |
Approved |
0.6798 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6798 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD6100 |
Approved |
0.6798 |
Remote Similarity |
NPD6099 |
Approved |
0.6794 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6778 |
Remote Similarity |
NPD2800 |
Approved |
0.6771 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6765 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.676 |
Remote Similarity |
NPD2344 |
Approved |
0.6748 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6746 |
Remote Similarity |
NPD1091 |
Approved |
0.6744 |
Remote Similarity |
NPD2798 |
Approved |
0.6743
|
Remote Similarity |
NPD7907 |
Approved |